CDX2 and cancer: Mutations in APC were also frequent in gastric cancers with CDX2 induction and SOX2 suppression (16.2% of cases), and the difference in prevalence compared with SOX2-maintained-expression cancers approached significance (Fisher’s exact test with p = 0.06).